Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1227207> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q1227207 subject Q52309.
- Q1227207 subject Q7139608.
- Q1227207 subject Q7335338.
- Q1227207 subject Q8789452.
- Q1227207 abstract "Oxantel is an anthelmintic. It has typically been used human and animal use as a standard treatment for intestinal worms. Oxantel is currently being experimented with for the treatment of periodontal disease by the Cooperative Research Centre for Oral Health Science (CRC). Professor Eric Reynolds (also the head of Dental School at the University of Melbourne, Australia) and his Associate Professor Stuart Dashper are currently testing its ability as a Fumarate reductase inhibitor. Fumarate reductase is an enzyme that has been found in the pathogenic bacteria in the biofilm in periodontal pockets. This bacteria has the ability to convert blood components into energy and for the bacteria to be virulent. Such bacteria would starve without this enzyme. As such, the role of the Oxantel as a fumarate reductase inhibitor would be to kill the bacteria responsible for periodontal disease.".
- Q1227207 atcPrefix "P02".
- Q1227207 atcSuffix "CC02".
- Q1227207 casNumber "68813-55-8".
- Q1227207 fdaUniiCode "94AJJ30D9E".
- Q1227207 iupacName "3-[(E)-2-(1-Methyl-5,6-dihydro-4H-pyrimidin-2-yl)ethenyl]phenol".
- Q1227207 pubchem "5281087".
- Q1227207 thumbnail Oxantel.png?width=300.
- Q1227207 wikiPageWikiLink Q52309.
- Q1227207 wikiPageWikiLink Q5508536.
- Q1227207 wikiPageWikiLink Q572294.
- Q1227207 wikiPageWikiLink Q7139608.
- Q1227207 wikiPageWikiLink Q7335338.
- Q1227207 wikiPageWikiLink Q8789452.
- Q1227207 atcPrefix "P02".
- Q1227207 atcSuffix "CC02".
- Q1227207 casNumber "68813".
- Q1227207 iupacName "3".
- Q1227207 pubchem "5281087".
- Q1227207 unii "94".
- Q1227207 type ChemicalSubstance.
- Q1227207 type Drug.
- Q1227207 type ChemicalObject.
- Q1227207 type Thing.
- Q1227207 type Q8386.
- Q1227207 comment "Oxantel is an anthelmintic. It has typically been used human and animal use as a standard treatment for intestinal worms. Oxantel is currently being experimented with for the treatment of periodontal disease by the Cooperative Research Centre for Oral Health Science (CRC). Professor Eric Reynolds (also the head of Dental School at the University of Melbourne, Australia) and his Associate Professor Stuart Dashper are currently testing its ability as a Fumarate reductase inhibitor.".
- Q1227207 label "Oxantel".
- Q1227207 depiction Oxantel.png.